InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the complete record of transactions filed by Blackford Quentin S., Chief Operating Officer. Officer active across 4 companies, notably DEXCOM INC. Aggregated, 12 disclosures have been published. Total volume traded: €11.5m. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
018,546 shares0
Common Stock
SEC:0001179110-22-003362:0·
03,036 shares0
Common Stock
SEC:0000805928-22-000046:0·
0101,979 shares0
Common Stock
SEC:0001388658-21-000141·
0101,979 shares0
Common Stock
SEC:0001388658-21-000141:0·
€4m7,639 shares@ €461.85410.014% mcap61.4% of flow
Common Stock
SEC:0001093557-21-000202·
€4m7,639 shares@ €461.85410.014% mcap30.7% of flow
Common Stock
SEC:0001093557-21-000202:0·
010,221 shares0
Common Stock
SEC:0001179110-21-006868·
010,221 shares0
Common Stock
SEC:0001179110-21-006868:0·
06,173 shares0
Common Stock
SEC:0000805928-21-000109·
06,173 shares0
Common Stock
SEC:0000805928-21-000109:0·
€2m7,223 shares@ €307.54880.0087% mcap38.6% of flow
Common Stock
SEC:0001093557-21-000161·
€2m7,223 shares@ €307.54880.0087% mcap19.3% of flow
Common Stock
SEC:0001093557-21-000161:0·
12 of 12 declarations
About Blackford Quentin S.
Quentin S. Blackford is the Chief Operating Officer and a Director at DEXCOM INC, Axogen, Inc., and Alphatec Holdings, Inc. In this role, he oversees daily operations and contributes to the overall strategy of the companies. DEXCOM INC is a leader in glucose monitoring technologies, while Axogen, Inc. and Alphatec Holdings, Inc. specialize in medical solutions. Quentin S. Blackford leverages his expertise to enhance operational efficiency and support growth.
